Mar 2, 2026 03:49PM
Mar 2, 2026 10:38AM
Mar 2, 2026 09:19AM
Mar 2, 2026 04:55AM
Feb 27, 2026 05:57PM
Feb 27, 2026 05:57PM
Feb 23, 2026 05:31PM Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
Feb 19, 2026 05:31PM
Feb 12, 2026 07:41AM
Feb 11, 2026 04:01PM
Jan 9, 2026 06:01PM
Jan 8, 2026 04:04PM
Jan 8, 2026 04:01PM
Nov 26, 2025 07:00AM Ascendis Pharma's (ASND) PDUFA Extension a Minor Issue - Cantor Fitzgerald
Nov 26, 2025 06:48AM
Nov 25, 2025 06:15PM
Nov 24, 2025 08:53AM
Nov 17, 2025 04:10PM
Nov 16, 2025 03:00PM
Nov 13, 2025 06:55AM
Nov 12, 2025 04:01PM Ascendis Pharma Reports Third Quarter 2025 Financial Results
Oct 8, 2025 04:01PM
Oct 8, 2025 04:01PM
Sep 23, 2025 08:59AM
Aug 7, 2025 04:01PM
Jul 28, 2025 07:00AM
Jul 28, 2025 07:00AM
Jun 16, 2025 07:00AM Dr. Jethro Ekuta Joins BP Logix Life Sciences Strategic Advisory Board
Jun 9, 2025 07:00AM
Jun 2, 2025 12:02PM
Jun 2, 2025 08:01AM
Jun 2, 2025 08:00AM
May 29, 2025 12:01PM
May 1, 2025 04:01PM
Mar 31, 2025 04:01PM Ascendis Pharma (ASND) Submits U.S. NDA for TransCon CNP for the Treatment of Children with Achondroplasia
Mar 31, 2025 04:01PM
Feb 20, 2025 11:01AM
Feb 15, 2025 10:00PM
Feb 13, 2025 07:15AM
Feb 12, 2025 04:01PM
Jan 12, 2025 05:00PM
Dec 19, 2024 08:30AM YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults
Dec 12, 2024 04:02PM
Dec 12, 2024 04:01PM
Dec 9, 2024 08:00AM
Dec 6, 2024 01:14PM
Dec 6, 2024 01:13PM
Nov 14, 2024 04:01PM
Nov 7, 2024 08:15AM Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
Sep 30, 2024 08:32AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All